These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9540951

  • 21. Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception.
    Qasba NT, Stutsman JW, Weaver GE, Jones KE, Daggy JK, Wilkinson TA.
    J Womens Health (Larchmt); 2020 Jun; 29(6):815-818. PubMed ID: 31990605
    [Abstract] [Full Text] [Related]

  • 22. Breastfeeding Perceptions and Behavior Among Postpartum Women Initiating Different Hormonally Systemic Contraceptive Methods.
    Wilson SF, Ponzini M, Wilson M, Holton S, Antell K, Medaglio D.
    J Hum Lact; 2023 Feb; 39(1):158-167. PubMed ID: 35786071
    [Abstract] [Full Text] [Related]

  • 23. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE, Upadhyay UD, Sokoloff A, Harper CC, Diedrich JT, Drey EA.
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate.
    Jimenez J, Ochoa M, Soler MP, Portales P.
    Contraception; 1984 Dec; 30(6):523-33. PubMed ID: 6241560
    [Abstract] [Full Text] [Related]

  • 25. Infant feeding and contraceptive practices among adolescents with a high teen pregnancy rate: a 3-year retrospective study.
    Glass TL, Tucker K, Stewart R, Baker TE, Kauffman RP.
    J Womens Health (Larchmt); 2010 Sep; 19(9):1659-63. PubMed ID: 20799897
    [Abstract] [Full Text] [Related]

  • 26. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM, Udoma EJ, Ukeme E.
    Ann Afr Med; 2010 Sep; 9(2):81-5. PubMed ID: 20587929
    [Abstract] [Full Text] [Related]

  • 27. Comparison of two strategies for the administration of injectable depot medroxyprogesterone acetate: among women who returned to a family planning clinic at three- or six-month intervals.
    Ferreira JM, Bottura BF, Gonçalves MP, Monteiro I, Bahamondes L.
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):408-11. PubMed ID: 27530899
    [Abstract] [Full Text] [Related]

  • 28. Long-acting contraceptives in adolescents.
    Tolaymat LL, Kaunitz AM.
    Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
    [Abstract] [Full Text] [Related]

  • 29. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [Abstract] [Full Text] [Related]

  • 30. Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant.
    Stevens-Simon C, Kelly L, Singer D.
    Fam Plann Perspect; 1999 May; 31(2):88-93. PubMed ID: 10224547
    [Abstract] [Full Text] [Related]

  • 31. Changing depot medroxyprogesterone acetate access at a faith-based institution.
    Guiahi M, McNulty M, Garbe G, Edwards S, Kenton K.
    Contraception; 2011 Sep; 84(3):280-4. PubMed ID: 21843694
    [Abstract] [Full Text] [Related]

  • 32. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 33. Spinal bone density in women using depot medroxyprogesterone contraception.
    Cundy T, Cornish J, Roberts H, Elder H, Reid IR.
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):569-73. PubMed ID: 9764630
    [Abstract] [Full Text] [Related]

  • 34. Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Raymond EG, Weaver MA, Louie KS, Tan YL, Bousiéguez M, Aranguré-Peraza AG, Lugo-Hernández EM, Sanhueza P, Goldberg AB, Culwell KR, Kaplan C, Memmel L, Sonalkar S, Jamshidi R, Winikoff B.
    Obstet Gynecol; 2016 Oct; 128(4):739-45. PubMed ID: 27607859
    [Abstract] [Full Text] [Related]

  • 35. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
    Pardthaisong T, Gray RH, McDaniel EB.
    Lancet; 1980 Mar 08; 1(8167):509-12. PubMed ID: 6102234
    [Abstract] [Full Text] [Related]

  • 36. Use of depot medroxyprogesterone acetate in Thai adolescents.
    Chotnopparatpattara P, Taneepanichskul S.
    Contraception; 2000 Sep 08; 62(3):137-40. PubMed ID: 11124361
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM, Gola SB, Weis M, Smaldone A.
    J Pediatr Adolesc Gynecol; 2016 Dec 08; 29(6):659-667. PubMed ID: 27386754
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment of depot medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in adolescents.
    Rager KM, Fowler A, Omar HA.
    ScientificWorldJournal; 2006 Mar 19; 6():353-5. PubMed ID: 16547584
    [Abstract] [Full Text] [Related]

  • 40. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
    Keder LM, Rulin MC, Gruss J.
    Am J Obstet Gynecol; 1998 Sep 19; 179(3 Pt 1):583-5. PubMed ID: 9757955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.